NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

生物相似藥白細胞介素的全球市場(2020年∼2030年):Covid-19的成長與變化

Biosimilar Interleukins Global Market Report 2020-30: COVID-19 Growth and Change

出版商 The Business Research Company 商品編碼 977384
出版日期 按訂單生產 內容資訊 英文 200 Pages
商品交期: 2-10個工作天內
價格
生物相似藥白細胞介素的全球市場(2020年∼2030年):Covid-19的成長與變化 Biosimilar Interleukins Global Market Report 2020-30: COVID-19 Growth and Change
出版日期: 按訂單生產內容資訊: 英文 200 Pages
簡介

本報告提供全球生物相似藥白細胞介素市場的相關調查,市場規模與預測,趨勢,策略,佔有率,成長及阻礙因素,各類型、用途、流通管道、地區/國家的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 摘要整理

第2章 市場特徵

第3章 市場規模與成長

  • 全球市場(2015-2019)
    • 市場成長要素
    • 阻礙市場要素
  • 全球市場預測(2019-2023F,2025F,2030F)

第4章 市場區隔

  • 全球市場及預測:各類型(2015-2019,2023F,2025F,2030F)
  • IL-17
  • IL-23
  • IL-1
  • IL-5
  • IL-6
  • 其他
  • 全球市場及預測:各用途(2015-2019,2023F,2025F,2030F)
  • 乾癬
  • 乾癬性關節炎
  • 類風濕性關節炎
  • 氣喘
  • 發炎性腸道疾病(IBD)
  • 其他
  • 全球市場及預測:各流通管道(2015-2019,2023F,2025F,2030F)
  • 醫院藥局
  • 線上藥局
  • 零售藥局
  • 診所
  • 研究機關

第5章 各地區/國家分析

  • 全球市場及預測:各地區(2015-2019,2023F,2025F,2030F)
  • 全球市場及預測:各國(2015-2019,2023F,2025F,2030F)

第6章 亞太地區

第7章 中國

第8章 印度

第9章 日本

第10章 澳洲

第11章 印尼

第12章 韓國

第13章 西歐

第14章 英國

第15章 德國

第16章 法國

第17章 東歐

第18章 俄羅斯

第19章 北美

第20章 美國

第21章 南美

第22章 巴西

第23章 中東

第24章 非洲

第25章 競爭情形和企業簡介

  • 競爭情形
  • 企業簡介
    • MabPharm
    • Gedeon Richter
    • Bio-Thera Solutions
    • Sorrento Therapeutics/MabTech
    • Sunshine Guojian Pharmaceutical

第26章 主要合併和收購

第27章 市場趨勢與策略

第28章 市場未來展望和潛力分析

第29章 附錄

目錄

“Biosimilar Interleukins Global Market Report 2020-30: COVID-19 Growth and Change” from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global biosimilar interleukins market.

This report focuses on biosimilar interleukins market which is experiencing strong growth. The report gives a guide to the biosimilar interleukins market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the biosimilar interleukins? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward?“ The Biosimilar Interleukins market global report” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider biosimilar interleukins market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the Covid 19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of Covid 19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The biosimilar interleukins market section of the report gives context. It compares the biosimilar interleukins market with other segments of the biosimilar interleukins market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, biosimilar interleukins indicators comparison.

Scope

Markets Covered:

  • 1)By Type: IL-17; IL-23; IL-1; IL-5; IL-6; Others
  • 2)By Application: Psoriasis; Psoriatic Arthritis; Rheumatoid Arthritis; Asthma; Inflammatory Bowel Disease (IBD); Others
  • 3)By Distribution Channel: Hospital Pharmacies; Online Pharmacies; Retail Pharmacies; Clinics; Research Institutes;
  • Companies Mentioned: MabPharm; Gedeon Richter; Bio-Thera Solutions; Sorrento Therapeutics/MabTech; Sunshine Guojian Pharmaceutical
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series:: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations:: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Biosimilar Interleukins Market Characteristics

3. Biosimilar Interleukins Market Size And Growth

  • 3.1. Global Biosimilar Interleukins Historic Market, 2015 - 2019, $ Billion
    • 3.1.1. Drivers Of The Market
    • 3.1.2. Restraints On The Market
  • 3.2. Global Biosimilar Interleukins Forecast Market, 2019 - 2023F, 2025F, 2030F, $ Billion
    • 3.2.1. Drivers Of The Market
    • 3.2.2. Restraints On the Market

4. Biosimilar Interleukins Market Segmentation

  • 4.1. Global Biosimilar Interleukins Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • IL-17
  • IL-23
  • IL-1
  • IL-5
  • IL-6
  • Others
  • 4.2. Global Biosimilar Interleukins Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Psoriasis
  • Psoriatic Arthritis
  • Rheumatoid Arthritis
  • Asthma
  • Inflammatory Bowel Disease (IBD)
  • Others
  • 4.3. Global Biosimilar Interleukins Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
  • Clinics
  • Research Institutes

5. Biosimilar Interleukins Market Regional And Country Analysis

  • 5.1. Global Biosimilar Interleukins Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 5.2. Global Biosimilar Interleukins Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

6. Asia-Pacific Biosimilar Interleukins Market

  • 6.1. Asia-Pacific Biosimilar Interleukins Market Overview
  • 6.2. Asia-Pacific Biosimilar Interleukins Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 6.3. Asia-Pacific Biosimilar Interleukins Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

7. China Biosimilar Interleukins Market

  • 7.1. China Biosimilar Interleukins Market Overview
  • 7.2. China Biosimilar Interleukins Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion
  • 7.3. China Biosimilar Interleukins Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion

8. India Biosimilar Interleukins Market

  • 8.1. India Biosimilar Interleukins Market Overview
  • 8.2. India Biosimilar Interleukins Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 8.3. India Biosimilar Interleukins Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

9. Japan Biosimilar Interleukins Market

  • 9.1. Japan Biosimilar Interleukins Market Overview
  • 9.2. Japan Biosimilar Interleukins Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 9.3. Japan Biosimilar Interleukins Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

10. Australia Biosimilar Interleukins Market

  • 10.1. Australia Biosimilar Interleukins Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 10.2. Australia Biosimilar Interleukins Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

11. Indonesia Biosimilar Interleukins Market

  • 11.1. Indonesia Biosimilar Interleukins Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 11.2. Indonesia Biosimilar Interleukins Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

12. South Korea Biosimilar Interleukins Market

  • 12.1. South Korea Biosimilar Interleukins Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 12.2. South Korea Biosimilar Interleukins Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

13. Western Europe Biosimilar Interleukins Market

  • 13.1. Western Europe Biosimilar Interleukins Market Overview
  • 13.2. Western Europe Biosimilar Interleukins Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 13.3. Western Europe Biosimilar Interleukins Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

14. UK Biosimilar Interleukins Market

  • 14.1. UK Biosimilar Interleukins Market Overview
  • 14.2. UK Biosimilar Interleukins Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 14.3. UK Biosimilar Interleukins Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

15. Germany Biosimilar Interleukins Market

  • 15.1. Germany Biosimilar Interleukins Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 15.2. Germany Biosimilar Interleukins Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

16. France Biosimilar Interleukins Market

  • 16.4. France Biosimilar Interleukins Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 16.5. France Biosimilar Interleukins Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

17. Eastern Europe Biosimilar Interleukins Market

  • 17.1. Eastern Europe Biosimilar Interleukins Market Overview
  • 17.2. Eastern Europe Biosimilar Interleukins Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 17.3. Eastern Europe Biosimilar Interleukins Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

18. Russia Biosimilar Interleukins Market

  • 18.1. Russia Biosimilar Interleukins Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 18.2. Russia Biosimilar Interleukins Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

19. North America Biosimilar Interleukins Market

  • 19.1. North America Biosimilar Interleukins Market Overview
  • 19.2. North America Biosimilar Interleukins Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 19.3. North America Biosimilar Interleukins Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

20. USA Biosimilar Interleukins Market

  • 20.1. USA Biosimilar Interleukins Market Overview
  • 20.2. USA Biosimilar Interleukins Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 20.3. USA Biosimilar Interleukins Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

21. South America Biosimilar Interleukins Market

  • 21.1. South America Biosimilar Interleukins Market Overview
  • 21.2. South America Biosimilar Interleukins Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 21.3. South America Biosimilar Interleukins Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

22. Brazil Biosimilar Interleukins Market

  • 22.1. Brazil Biosimilar Interleukins Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 22.2. Brazil Biosimilar Interleukins Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

23. Middle East Biosimilar Interleukins Market

  • 23.1. Middle East Biosimilar Interleukins Market Overview
  • 23.2. Middle East Biosimilar Interleukins Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 23.3. Middle East Biosimilar Interleukins Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

24. Africa Biosimilar Interleukins Market

  • 24.1. Africa Biosimilar Interleukins Market Overview
  • 24.2. Africa Biosimilar Interleukins Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 24.3. Africa Biosimilar Interleukins Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

25. Biosimilar Interleukins Market Competitive Landscape And Company Profiles

  • 25.1. Biosimilar Interleukins Market Competitive Landscape
  • 25.2. Biosimilar Interleukins Market Company Profiles
    • 25.2.1. MabPharm
      • 25.2.1.1. Overview
      • 25.2.1.2. Products and Services
      • 25.2.1.3. Strategy
      • 25.2.1.4. Financial Performance
    • 25.2.2. Gedeon Richter
      • 25.2.2.1. Overview
      • 25.2.2.2. Products and Services
      • 25.2.2.3. Strategy
      • 25.2.2.4. Financial Performance
    • 25.2.3. Bio-Thera Solutions
      • 25.2.3.1. Overview
      • 25.2.3.2. Products and Services
      • 25.2.3.3. Strategy
      • 25.2.3.4. Financial Performance
    • 25.2.4. Sorrento Therapeutics/MabTech
      • 25.2.4.1. Overview
      • 25.2.4.2. Products and Services
      • 25.2.4.3. Strategy
      • 25.2.4.4. Financial Performance
    • 25.2.5. Sunshine Guojian Pharmaceutical
      • 25.2.5.1. Overview
      • 25.2.5.2. Products and Services
      • 25.2.5.3. Strategy
      • 25.2.5.4. Financial Performance

26. Key Mergers And Acquisitions In The Biosimilar Interleukins Market

27. Biosimilar Interleukins Market Trends And Strategies

28. Biosimilar Interleukins Market Future Outlook and Potential Analysis

29. Appendix

  • 29.1. Abbreviations
  • 29.2. Currencies
  • 29.3. Research Inquiries
  • 29.4. The Business Research Company
  • 29.5. Copyright And Disclaimer